- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06201546
Comparison of Abdominal Plane Blocks in Postoperative Pain Control in Patients Undergoing LSG
Comparison of Abdominal Plane Blocks in Terms of Efficiency and Complications in Postoperative Pain Control in Patients Undergoing Laparoscopic Sleeve Gastrectomy
Study Overview
Status
Intervention / Treatment
Detailed Description
After laparoscopic sleeve gastrectomy, patients have pain due to surgery. Different analgesic methods are preferred for pain relief. One of the methods used for this purpose is regional anesthesia. Modified thoracoabdominal plane block-perichondrial approach (M-TAPA) and transversus abdominis plane (TAP) block are also plan blocks used for this purpose. TAP block is formed by injecting local anesthetic into the neurofacial space between the transversus abdominis muscle and the internal oblique muscle through the Petit triangle in the lumbar region. TAP block creates dermatomal sensory block in the lower, lower thoracic and upper lumbar abdominal afferents. It is thought that the modified thoracoabdominal plane block-perichondrial approach (M-TAPA), which is a block frequently used in upper abdomen surgeries in recent years, can provide effective analgesia in LSG surgeries. M-TAPA block is created by administering local anesthetic between the transverse abdominis muscle and the internal oblique muscle with a single injection under the costal cartilage under ultrasound guidance. With M-TAPA, analgesia can be provided in thoracic 4 and thoracic 11-12 dermatomes.
Blocking of T4-12 nerve endings may be required in LSG surgeries, since gastric innervation and thoracic inlets are located in the upper abdomen dermatomes. In studies, the use of M-TAPA block in upper abdominal surgeries may be effective in the management of analgesia in participants. In this study the investigators aimed that, compression in terms of efficiency and complications TAP and M-TAPA blocks, who is undergoing laparoscopic sleeve gastrectomy. The investigators aims to examine whether M-TAPA block provides more effective analjesia than TAP block in upper abdomen surgeries, and whether there is any difference in terms of nausea- vomiting and need for additional analgesics. After obtaining ethical committee approval (12.01.2023/1), between January 26, 2023, and May 15, 2024, 60 patients undergoing laparoscopic sleeve gastrectomy with American Society of Anesthesiologists (ASA) II-III status provide informed consent. Participants who are planing to receive M-TAPA block defines as Group M-TAPA, and those who receive TAP block defines as Group TAP, with 30 patients in each group.The participitans will be observed for postoperative 24 hours with numeric rating score (NRS), postoperative nausea-vomiting score (PNVS) and in terms of need for additional analgesic dose.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey
- Gamze Nur Teke
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients between the ages of 18-65, including the ASA I-III group, who underwent laparoscopic sleeve gastrectomy by the General Surgery clinic between January 26, 2023 and May 15, 2023
Exclusion Criteria:
- Patients with coronary artery disease
- Patients with cerebrovascular disease
- Patients with peripheral artery disease
- History of chronic analgesic use
- Patients with coagulopathy
- Patients not between the ages of 18-65
- Patients with hepatic and/or renal insufficiency
- Patients with missing information in the information form
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: TAP block
Transversus Abdominal Plane Block aplied after LSG.
In TAP block local anesthetic(%0,25 bupivacaine-20ml)will be administrated the between the transversus abdominis muscle and the internal abdominal muscle fascia.
|
TAP block will be administrated after LSG.
In TAP block local anesthetic(%0,25 bupivacaine-20ml)will be administrated the between the transversus abdominis muscle and the internal abdominal muscle fascia.
|
Active Comparator: m-TAPA block
Modified-Thoracoabdominal Plane Block-pericondrial approach aplied after LSG.
In m-TAPA block local anesthetic (0.25% bupivacaine-20ml) will be administrated between the transversus abdominis muscle and the internal abdominal muscle fascia under the costochondrial region.
|
m-TAPA block will be administrated after LSG.
In m-TAPA block local anesthetic (0.25% bupivacaine-20ml) will be administrated between the transversus abdominis muscle and the internal abdominal muscle fascia under the costochondrial region
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Numeric Rate Score (NRS)
Time Frame: It will be evaluated with (which ), at PACU 5,15, 30th minutes and postoperative 1, 3, 6, 12, 24th hours
|
NRS is a 0 to 10 scale that describes pain from good to worst.
|
It will be evaluated with (which ), at PACU 5,15, 30th minutes and postoperative 1, 3, 6, 12, 24th hours
|
Visual Analog Scale (VAS)
Time Frame: PACU 5,15, 30th minutes and postoperative 1, 3, 6, 12, 24th hours
|
VAS is a 10-centimeter scale and is used to evaluate pain.
|
PACU 5,15, 30th minutes and postoperative 1, 3, 6, 12, 24th hours
|
Pain Controlled Analgesia (PCA)
Time Frame: PACU 5,15, 30th minutes and postoperative 1, 3, 6, 12, 24th hours
|
PCA is includes 300mg Tramadol/100 ml SF- no infusion, 5cc bolus, 15 minutes lock
|
PACU 5,15, 30th minutes and postoperative 1, 3, 6, 12, 24th hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
postoperative nausea and vomiting scale (PNV)
Time Frame: It will be evaluated with nause and vomiting score at PACU 5,15, 30th minutes and postoperative 1, 3, 6, 12, 24th hours
|
PNV is a 0 to 4 scale that describes nausea and vomiting from good to worst.
|
It will be evaluated with nause and vomiting score at PACU 5,15, 30th minutes and postoperative 1, 3, 6, 12, 24th hours
|
Collaborators and Investigators
Investigators
- Study Director: arzu yıldırım ar, Fatih Sultan Mehmet Training and Research Hospital
Publications and helpful links
General Publications
- McDonnell JG, O'Donnell B, Curley G, Heffernan A, Power C, Laffey JG. The analgesic efficacy of transversus abdominis plane block after abdominal surgery: a prospective randomized controlled trial. Anesth Analg. 2007 Jan;104(1):193-7. doi: 10.1213/01.ane.0000250223.49963.0f. Erratum In: Anesth Analg. 2007 May;104(5):1108.
- O'Donnell BD, McDonnell JG, McShane AJ. The transversus abdominis plane (TAP) block in open retropubic prostatectomy. Reg Anesth Pain Med. 2006 Jan-Feb;31(1):91. doi: 10.1016/j.rapm.2005.10.006. No abstract available. Erratum In: Reg Anesth Pain Med. 2006 May-Jun;31(3):286. McDonnell, John G [added]; McShane, Alan J [added].
- McDonnell JG, O'Donnell BD, Farrell T, Gough N, Tuite D, Power C, Laffey JG. Transversus abdominis plane block: a cadaveric and radiological evaluation. Reg Anesth Pain Med. 2007 Sep-Oct;32(5):399-404. doi: 10.1016/j.rapm.2007.03.011.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- gamzenurteke-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anesthesia and Analgesia
-
Grünenthal GmbHTerminatedAnalgesia | Anesthesia, Local | AnesthesiaNetherlands
-
Becton, Dickinson and CompanyRecruitingAnalgesia | AnesthesiaGermany, Austria, Spain
-
Becton, Dickinson and CompanyCromsourceCompletedAnalgesia | AnesthesiaGermany, Austria, Spain, Finland, Switzerland
-
Università degli Studi di BresciaAzienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaCompletedAnalgesia | AnesthesiaItaly
-
University of AlbertaTerminated
-
Bezmialem Vakif UniversityCompletedAnalgesia | Anesthesia | Sedation | Airway Complication of AnesthesiaTurkey
-
Cairo UniversityCompletedAnalgesia | Anesthesia, LocalEgypt
-
Konya City HospitalNot yet recruitingAnalgesia | Anesthesia, Local
-
Uludag UniversityNot yet recruiting
-
Hôpital Privé SévignéCompletedAnalgesia | Rehabilitation | AnesthesiaFrance
Clinical Trials on TAP block group
-
Yuzuncu Yıl UniversityCompletedComparison | EvaluationTurkey
-
Ankara City Hospital BilkentCompletedPostoperative Pain, Acute | Analgesia, Patient-ControlledTurkey
-
Biruni UniversityCompleted
-
University of Massachusetts, WorcesterNot yet recruitingPost-operative Pain
-
Tokat Gaziosmanpasa UniversityCompletedIntraoperative Complications | Abdominal Hysterectomy (& Wertheim)Turkey
-
Aga Khan UniversityCompletedSubcostal TAP Block for Multiport Laparoscopic Cholecystectomy
-
Spectrum Health HospitalsCompletedPostoperative PainUnited States
-
Liverpool University Hospitals NHS Foundation TrustCompletedPain | Disorder Related to Renal TransplantationUnited Kingdom
-
Federal University of São PauloUnknownRenal Insufficiency, Chronic | Kidney Transplantation | Acute Pain | Anesthesia, ConductionBrazil